New drug combo tested for rare blood cancer
Disease control
Recruiting now
This early-stage study is testing a new drug called imetelstat when given alongside an existing drug, ruxolitinib, for people with myelofibrosis, a serious bone marrow cancer. The main goals are to find a safe dose and see if the combination helps reduce symptoms like fatigue and…
Phase: PHASE1 • Sponsor: Geron Corporation • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC